Global /Japan /Healthcare /Medical Devices /4978
chevron_leftBack
ReproCELL Inc. logo

ReproCELL Inc.

4978
TSE: 4978 Delayed
172JPY 0.6%
1.07 USD
As of 13 June 2026, ReproCELL Inc. has a market cap of $101.51M USD, ranking #25449 globally and #2235 in Japan. It ranks #2278 in the Healthcare sector, and #472 in the Medical Devices industry.
Global Rank
25449
Country Rank
2235
Sector Rank
2278
Industry Rank
472
Key Stats
Market Cap
$101.51MUSD
16.25B JPY
Enterprise Value
$58.63MUSD
9.4B JPY
Revenue (TTM)
$15.74MUSD
2.52B JPY
EBITDA (TTM)
-$3.54MUSD
-568.25M JPY
Net Income (TTM)
-$2.02MUSD
-324.0M JPY
EBITDA Margin
-23%
Profit Margin
-13%
PS Ratio
6.5
PB Ratio
1.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Chikafumi Yokoyama open_in_new
Employees
99
Founded
2003
Website
reprocell.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.6% -3.4% -6.6% 5.6% -5.5% 13%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
4978
株式会社リプロセル
ISIN: JP3974770004
Shares Out.:
95.031M1 Shares Float: 91.034M2
TV:
SA:
YF:
GF:
BA:
MS:
172 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About ReproCELL Inc.

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-derived exosomes. The company also provides Alvetex 3D, a cell culture system; Alvetex, an advanced tissue bioengineering system; EZSPHERE Multiwell Dishes and Plates; KOKEN atelocollagen; ABLE Biott bioreactor systems; and 2mag stirrer systems. In addition, It offers research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

Similar Companies

Industry: Medical Devices (Japan)
Name
Market Cap diff.
PE
7741
$61.41B
9.83T JPY
60K%
40.0
$22.07B
3.53T JPY
22K%
13.0
4543
$18.94B
3.03T JPY
19K%
23.7
7733
$10.76B
1.72T JPY
10K%
20.7
7701
$6.58B
1.05T JPY
6K%
18.6
$5.47B
875.04B JPY
5K%
50.1
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
171K%
25.8
$160.73B
158K%
56.7
$159.07B
157K%
25.6
DHR
$126.55B
125K%
34.7
SYK
$120.69B
119K%
38.3
MDT
$101.9B
100K%
22.2
chevron_leftBack